drugset / Trial / NCT01052363

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

NCT01052363

Phase 1 Withdrawn West Virginia University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Pilot Trial of CA4P with Avastin in Recurrent Gliomas

Timeline

Start
2010-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody
Subject fosbretabulin Small molecule